Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia

D. Price, K. Bichel, D. West, V. L. Ashton, R. Stewart (Aberdeen, Cambridge, United Kingdom)

Source: International Congress 2014 – COPD exacerbations
Session: COPD exacerbations
Session type: Poster Discussion
Number: 525
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Price, K. Bichel, D. West, V. L. Ashton, R. Stewart (Aberdeen, Cambridge, United Kingdom). Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia. Eur Respir J 2014; 44: Suppl. 58, 525

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Integrated care reduces hospital utilization among patients with severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014


Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014


COPD on anti-GERD therapy remains at higher risk for severe exacerbation
Source: International Congress 2014 – COPD exacerbations
Year: 2014

The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


Gender differences in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014


The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Hospital readmissions and social deprivation in asthma and COPD
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014



Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations
Source: International Congress 2014 – COPD markers
Year: 2014


COPD: Influence of patients’ nutritive status on the exacerbations rate
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014


Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013


Inter-relationship of different types of respiratory symptoms in COPD
Source: International Congress 2014 – Comorbidities
Year: 2014

Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Mortality predictors in stable COPD
Source: International Congress 2014 – Predictors
Year: 2014


Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016